Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Molls

Showing results (131-140 of 137) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 137 results.
European Journal of Nuclear Medicine and Molecular Imaging|September 5, 2014
11C-Choline PET/pathology image coregistration in primary localized prostate cancerAnca-Ligia Grosu, Gregor Weirich, Christina Wendl, et al.
Plos One|October 20, 2017
Increased cell survival and cytogenetic integrity by spatial dose redistribution at a compact synchrotron X-ray sourceKarin Burger, Katarina Ilicic, Martin Dierolf, et al.
International Journal of Colorectal Disease|August 16, 2008
Using Q-RT-PCR to measure cyclin D1, TS, TP, DPD, and Her-2/neu as predictors for response, survival, and recurrence in patients with esophageal squamous cell carcinoma following radiochemotherapyBjörn L D M Brücher, Gisela Keller, Martin Werner, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 28, 2014
Stereotactic body radiotherapy for centrally located stage I NSCLC: a multicenter analysisDaniel H Schanne, Ursula Nestle, Michael Allgäuer, et al.
Radiation and Environmental Biophysics|May 11, 2011
Scanning irradiation device for mice in vivo with pulsed and continuous proton beamsChristoph Greubel, Walter Assmann, Christian Burgdorf, et al.
Frontiers in Immunology|May 1, 2015
Heat Shock Protein 70 (Hsp70) Peptide Activated Natural Killer (NK) Cells for the Treatment of Patients with Non-Small Cell Lung Cancer (NSCLC) after Radiochemotherapy (RCTx) - From Preclinical Studies to a Clinical Phase II TrialHanno M Specht, Norbert Ahrens, Christiane Blankenstein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2020
Targeted Natural Killer Cell-Based Adoptive Immunotherapy for the Treatment of Patients with NSCLC after Radiochemotherapy: A Randomized Phase II Clinical TrialGabriele Multhoff, Sophie Seier, Stefan Stangl, et al.
Pageof 14

Showing results (131-140 of 137) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 137 results.
European Journal of Nuclear Medicine and Molecular Imaging|September 5, 2014
11C-Choline PET/pathology image coregistration in primary localized prostate cancerAnca-Ligia Grosu, Gregor Weirich, Christina Wendl, et al.
Plos One|October 20, 2017
Increased cell survival and cytogenetic integrity by spatial dose redistribution at a compact synchrotron X-ray sourceKarin Burger, Katarina Ilicic, Martin Dierolf, et al.
International Journal of Colorectal Disease|August 16, 2008
Using Q-RT-PCR to measure cyclin D1, TS, TP, DPD, and Her-2/neu as predictors for response, survival, and recurrence in patients with esophageal squamous cell carcinoma following radiochemotherapyBjörn L D M Brücher, Gisela Keller, Martin Werner, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 28, 2014
Stereotactic body radiotherapy for centrally located stage I NSCLC: a multicenter analysisDaniel H Schanne, Ursula Nestle, Michael Allgäuer, et al.
Radiation and Environmental Biophysics|May 11, 2011
Scanning irradiation device for mice in vivo with pulsed and continuous proton beamsChristoph Greubel, Walter Assmann, Christian Burgdorf, et al.
Frontiers in Immunology|May 1, 2015
Heat Shock Protein 70 (Hsp70) Peptide Activated Natural Killer (NK) Cells for the Treatment of Patients with Non-Small Cell Lung Cancer (NSCLC) after Radiochemotherapy (RCTx) - From Preclinical Studies to a Clinical Phase II TrialHanno M Specht, Norbert Ahrens, Christiane Blankenstein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2020
Targeted Natural Killer Cell-Based Adoptive Immunotherapy for the Treatment of Patients with NSCLC after Radiochemotherapy: A Randomized Phase II Clinical TrialGabriele Multhoff, Sophie Seier, Stefan Stangl, et al.
Pageof 14